Please login to the form below

Not currently logged in
Email:
Password:

UK Dementia Research Institute names director

Prof Bart De Strooper to lead the national institute

UK Dementia Research Prof Bart De StrooperProf Bart De Strooper has been appointed as director of the UK Dementia Research Institute, and will lead the venture from University College London.

In his new role, Prof De Strooper will work with the institute's founding partners - the Medical Research Council, Alzheimer's Society and Alzheimer's Research UK - to develop new therapeutics and diagnostics to accelerate the pace of dementia research.

Prof De Strooper is currently a professor of molecular medicine at the University of Leuven and leads its laboratory for the research of neurodegenerative diseases.

He also serves as the departmental director of the VIB Center for the Biology of Disease at VIB at the Flemish Institute for Biotechnology, and has been a visiting professor at UCL since 2013.

Prof De Strooper said: “I am delighted to be directing a world-leading initiative with as much as potential as the UK DRI.

“The UK research landscape is brimming with talent and opportunity and, thanks to the NHS, research is closely allied to patients.

“My vision is to establish a unique environment with a diverse and interdisciplinary team ready to undertake creative and innovative research.”

He added: “I want the Institute to be the most exciting place in the world for breakthrough dementias research.

“To achieve this we need to not only join forces and facilitate closer interaction between leading groups currently working in this area, but also bring together talented scientists in completely different and previously overlooked fields that could contribute towards our understanding of the dementias.

“We have a huge amount of discovery science to do - and I want to see real surprises.”

16th December 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Healthcare Communications

Founded in 2011, Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective,...

Latest intelligence

Precision medicine and the changing role of the healthcare professional
The growth of precision medicine introduces a shift away from treating the population as a whole, to treating each patient as an individual. How does this change the role of...
How will Sustainability and Transformation Plans (STPs) change the NHS commissioning landscape?
Sue Thomas and Paul Midgley, of Wilmington Healthcare, take a look at new commissioning structures and what they mean for pharma...
eyeforpharma Barcelona 2017 highlights: Industry at the brink of transformation
Hear what Anthill's delegates reported back from the biggest eyeforpharma Barcelona yet....

Infographics